SBRT compared to sorafenib in locally advanced hepatocellular carcinoma: a propensity score analysis

被引:0
|
作者
Gkika, E. [1 ]
Brunner, T. [2 ]
Abbasi-Senger, N. [3 ]
Alheit, H.
Baus, W. [4 ]
Blanck, O. [5 ]
Gerum, S. [6 ]
Guckenberger, M. [7 ]
Habermehl, D. [8 ]
Ostheimer, C. [9 ]
Riesterer, O. [7 ]
Tamihardja, J. [10 ]
Pinato, D. J. [11 ]
Rimassa, L. [12 ]
Pressiani, T. [12 ]
Schultheiss, M. [13 ]
Sharma, R. [11 ]
Burlone, M. E. [14 ]
Pirisi, M. [14 ]
Kudo, M. [15 ]
Park, J. W. [16 ]
Neumann-Haefelin, C. [17 ]
Grosu, A. [18 ]
Thimme, R. [17 ]
Bettinger, D. [17 ]
机构
[1] Uniklin Freiburg, Radiat Oncol, Freiburg, Germany
[2] Univ Magdeburg, Radiat Oncol, Magdeburg, Germany
[3] Univ Jena, Radiat Oncol, Jena, Germany
[4] Univ Hosp Cologne, Radiat Oncol, Cologne, Germany
[5] Univ Med Ctr Schleswig Holstein, Dept Radiat Oncol, Campus Kiel, Kiel, Germany
[6] Ludwig Maximilians Univ Munchen, Dept Radiat Oncol, Munich, Germany
[7] Univ Hosp Zurich, Dept Radiat Oncol, Zurich, Switzerland
[8] Tech Univ Munich, Dept Radiat Oncol, Klinikum Rechts Isar, Munich, Germany
[9] Martin Luther Univ Halle Wittenberg, Dept Radiat Oncol, Halle, Germany
[10] Univ Hosp Wurzburg, Dept Radiat Oncol, Wurzburg, Germany
[11] Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp, London, England
[12] Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Med Oncol & Hematol Unit, Milan, Italy
[13] Univ Freiburg, Med Ctr, Dept Med 2, Freiburg, Germany
[14] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy
[15] Kindai Univ, Sch Med, Dept Gastroenterol & Hepatol, Osakasayama, Japan
[16] Natl Canc Ctr Hosp, Ctr Liver Canc, Goyang, South Korea
[17] Univ Freiburg, Med Ctr, Dept Med 2, Freiburg, Germany
[18] Univ Freiburg, Dept Radiat Oncol, Med Ctr, Freiburg, Germany
关键词
D O I
10.1016/S0167-8140(19)31231-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO-0811
引用
收藏
页码:S423 / S423
页数:1
相关论文
共 50 条
  • [21] Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
    Henry W. C. Leung
    Chung-Feng Liu
    Agnes L. F. Chan
    Radiation Oncology, 11
  • [22] Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
    Leung, Henry W. C.
    Liu, Chung-Feng
    Chan, Agnes L. F.
    RADIATION ONCOLOGY, 2016, 11
  • [23] Complete regression following sorafenib in unresectable, locally advanced hepatocellular carcinoma
    Moroni, Marco
    Zanlorenzi, Laura
    FUTURE ONCOLOGY, 2013, 9 (08) : 1231 - 1237
  • [24] Combining cetuximab with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: A propensity score analysis
    Xia, Wei-Xiong
    Liang, Hu
    Lv, Xing
    Wang, Lin
    Qian, Chao-Nan
    Ye, Yan-Fang
    Ke, Liang-Ru
    Qiu, Wen-Ze
    Yu, Ya-Hui
    Huang, Xin-Jun
    Liu, Guo-Ying
    Zhao, Chong
    Xiang, Yan-Qun
    Guo, Xiang
    ORAL ONCOLOGY, 2017, 67 : 167 - 174
  • [25] Sorafenib as a postoperative adjuvant therapy in patients with hepatocellular carcinoma and microvascular invasion: A propensity score matching analysis
    Zhang, Xiu-Ping
    Chai, Zong-Tao
    Gao, Yu-Zhen
    Ding, Jin
    Cong, Wen-Ming
    Lau, Wan Yee
    Cheng, Shuqun
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Combined Stereotactic Body Radiotherapy and Immunotherapy Versus Transarterial Chemoembolization in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
    Chiang, Chi-Leung
    Chiu, Keith Wan-Hang
    Lee, Francis Ann-Shing
    Kong, Feng-Ming Spring
    Chan, Albert Chi-Yan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] Propensity score-based comparison of SBRT versus thermal ablation for hepatocellular carcinoma
    Franzese, C.
    Poretti, D.
    Comito, T.
    Muglia, R.
    Lo Faro, L.
    Ceriani, C.
    Pedicini, V.
    Teriaca, A.
    Lanza, E.
    D'antuono, F.
    Solbiati, L.
    Mancosu, P.
    Tomatis, S.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S180 - S180
  • [28] Sorafenib in advanced hepatocellular carcinoma
    Sauerbruch, T.
    Gonzalez-Carmona, A. M.
    Nitschmann, S.
    INTERNIST, 2009, 50 (11): : 1290 - 1292
  • [29] Sorafenib in advanced hepatocellular carcinoma
    Llovet, Josep M.
    Ricci, Sergio
    Mazzaferro, Vincenzo
    Hilgard, Philip
    Gane, Edward
    Blanc, Jean-Frederic
    Cosme de Oliveira, Andre
    Santoro, Armando
    Raoul, Jean-Luc
    Forner, Alejandro
    Schwartz, Myron
    Porta, Camillo
    Zeuzem, Stefan
    Bolondi, Luigi
    Greten, Tim F.
    Galle, Peter R.
    Seitz, Jean-Francois
    Borbath, Ivan
    Haussinger, Dieter
    Giannaris, Tom
    Shan, Minghua
    Moscovici, Marius
    Voliotis, Dimitris
    Bruix, Jordi
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04): : 378 - 390
  • [30] Sorafenib for Advanced Hepatocellular Carcinoma
    Shingina, Alexandra
    Hashim, ALMoutaz
    Haque, Mazhar
    Suen, Michael W.
    Yoshida, Eric M.
    Gill, Sharlene
    Weiss, Alan
    GASTROENTEROLOGY, 2012, 142 (05) : S42 - S42